Editor's Note The Food & Drug Administration (FDA) on May 6 issued a guidance to implement section 3121 of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) as it relates to shortages and potential shortages of medical devices occurring during the COVID-19 pandemic. Manufacturers are required to notify…

Read More

Editor's Note Researchers at Northwestern University in Chicago are using artificial intelligence (AI) to expedite the search for COVID-19 treatments and vaccines by shortening the expert review period. The AI tool prioritizes research that has the most potential to produce real solutions and ignores research that is unlikely to yield…

Read More

Editor's Note Cornell University researchers studying the structure of the SARS-CoV-2 virus have found a unique feature that could explain why it is so transmissible between humans. The researchers identified a structural loop in the SARS-CoV-2 spike protein (ie, the area of the virus that facilitates entry into a cell)…

Read More

Editor's Note The Centers for Disease Control and Prevention (CDC) on May 1 announced the launch of the “SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES)” consortium. This network of laboratories will speed the release of SARS-CoV-2 sequence data into the public domain for use by public…

Read More

Editor's Note This year, the American Nurses Association has extended the traditional National Nurses Week to a month of recognition, May 1-31. National Nurses Day, May 6, marks the beginning of National Nurses Week, which ends on May 12, the 200th anniversary of Florence Nightingale’s birthday. This year’s theme is “Nurses…

Read More

Editor's Note The Centers for Disease Control and Prevention on May 1 updated its weekly surveillance summary of COVID-19 activity in the US ending April 25. Among the updates: The percentage of specimens testing positive for SARS-CoV-2 decreased at public health and commercial laboratories and remained similar at clinical labs.…

Read More

Editor's Note In this randomized, double-blind, placebo-controlled, multicenter trial of remdesivir for the treatment of COVID-19, remdesivir was not associated with statistically significant clinical benefits. For the analysis, 237 patients were randomly assigned to either a treatment group with remdesivir (158 patients) or placebo (79 patients). Remdesivir use was not…

Read More

Editor's Note Abbott’s new COVID-19 antibody test that has 99% sensitivity and specificity has been given CE Mark approval for use across Europe, the April 29 Mass Device reports. The test is 99% accurate in identifying the IgG protein in patients infected by COVID-19, 14 days after symptoms develop. Abbott…

Read More

Editor's Note In this proof-of-concept study, a new lateral flow immunoassay developed by researchers from China can quickly detect antibodies against SARS-COV-2, which appear as a bright orange line when placed on a fluorescence reader. The test, which is based on a technique similar to what is used in home…

Read More

Editor's Note European regulators have approved Siemens Healthineers’ molecular Fast Track Diagnostics SARS-CoV-2 Assay, which has 100% specificity and sensitivity. The new assay uses real-time polymerase chain reaction (PCR) to detect ribonucleic acid (RNA) from this virus. The company plans to ship more than 1.3 million tests per month worldwide…

Read More